Literature DB >> 29414066

Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming.

Paola Fisicaro1, Carolina Boni1, Valeria Barili1, Diletta Laccabue1, Carlo Ferrari2.   

Abstract

HBV-specific T cells play a key role in antiviral protection and failure to control HBV is associated with severely dysfunctional T cell responses. Therefore, functional T cell reconstitution represents a potential way to treat chronically infected patients. The growing understanding of the dysregulated transcriptional/epigenetic and metabolic programs underlying T cell exhaustion allows to envisage functional T cell reconstitution strategies based on the combined/sequential use of compounds able to induce decline of antigen load, checkpoint modulation, metabolic and epigenetic reprogramming with possible boosting of functionally restored responses by specific vaccines.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29414066     DOI: 10.1016/j.coviro.2018.01.003

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  11 in total

Review 1.  Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad.

Authors:  Marc G Ghany; Jordan J Feld; Kyong-Mi Chang; Henry L Y Chan; Anna S F Lok; Kumar Visvanathan; Harry L A Janssen
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-02-10

2.  Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver.

Authors:  Daniel Traum; Yue J Wang; Kathleen B Schwarz; Jonathan Schug; David Kh Wong; Harry LA Janssen; Norah A Terrault; Mandana Khalili; Abdus S Wahed; Karen F Murray; Phillip Rosenthal; Simon C Ling; Norberto Rodriguez-Baez; Richard K Sterling; Daryl Ty Lau; Timothy M Block; Michael D Feldman; Elizabeth E Furth; William M Lee; David E Kleiner; Anna S Lok; Klaus H Kaestner; Kyong-Mi Chang
Journal:  JCI Insight       Date:  2021-04-08

Review 3.  HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications.

Authors:  Carolina Boni; Valeria Barili; Greta Acerbi; Marzia Rossi; Andrea Vecchi; Diletta Laccabue; Amalia Penna; Gabriele Missale; Carlo Ferrari; Paola Fisicaro
Journal:  Int J Mol Sci       Date:  2019-06-05       Impact factor: 5.923

Review 4.  Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches.

Authors:  Paola Fisicaro; Valeria Barili; Marzia Rossi; Ilaria Montali; Andrea Vecchi; Greta Acerbi; Diletta Laccabue; Alessandra Zecca; Amalia Penna; Gabriele Missale; Carlo Ferrari; Carolina Boni
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

5.  Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection.

Authors:  Valeria Barili; Paola Fisicaro; Barbara Montanini; Greta Acerbi; Anita Filippi; Giovanna Forleo; Chiara Romualdi; Manuela Ferracin; Francesca Guerrieri; Giuseppe Pedrazzi; Carolina Boni; Marzia Rossi; Andrea Vecchi; Amalia Penna; Alessandra Zecca; Cristina Mori; Alessandra Orlandini; Elisa Negri; Marco Pesci; Marco Massari; Gabriele Missale; Massimo Levrero; Simone Ottonello; Carlo Ferrari
Journal:  Nat Commun       Date:  2020-01-30       Impact factor: 14.919

6.  CD45: a critical regulator in immune cells to predict severe and non-severe COVID-19 patients.

Authors:  Mingming Jin; Nannan Shi; Meng Wang; Chunzi Shi; Shengjie Lu; Qing Chang; Shuang Sha; Yun Lin; Yingmin Chen; Hui Zhou; Kaiyi Liang; Xuyuan Huang; Yuxin Shi; Gang Huang
Journal:  Aging (Albany NY)       Date:  2020-10-16       Impact factor: 5.682

Review 7.  Recent Advances in Understanding, Diagnosing, and Treating Hepatitis B Virus Infection.

Authors:  Magda Rybicka; Krzysztof Piotr Bielawski
Journal:  Microorganisms       Date:  2020-09-15

8.  The therapeutic effect of IL-21 combined with IFN-γ inducing CD4+CXCR5+CD57+T cells differentiation on hepatocellular carcinoma.

Authors:  Changlin Zhao; Xianlin Wu; Jia Chen; Guoqiang Qian
Journal:  J Adv Res       Date:  2021-06-01       Impact factor: 10.479

Review 9.  Tumor necrosis family receptor superfamily member 9/tumor necrosis factor receptor-associated factor 1 pathway on hepatitis C viral persistence and natural history.

Authors:  Julia Peña-Asensio; Eduardo Sanz-de-Villalobos; Joaquín Miquel; Juan Ramón Larrubia
Journal:  World J Hepatol       Date:  2020-10-27

Review 10.  Cellular and Molecular Mechanisms of CD8+ T Cell Differentiation, Dysfunction and Exhaustion.

Authors:  Daniel J Verdon; Matthias Mulazzani; Misty R Jenkins
Journal:  Int J Mol Sci       Date:  2020-10-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.